{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,20]],"date-time":"2026-11-20T21:54:56Z","timestamp":1795211696565,"version":"4.10.3"},"reference-count":147,"publisher":"Wiley","issue":"2","license":[{"start":{"date-parts":[[2015,11,24]],"date-time":"2015-11-24T00:00:00Z","timestamp":1448323200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["CA A Cancer J Clinicians"],"published-print":{"date-parts":[[2016,3]]},"abstract":"<jats:p>\n                    <jats:ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" xlink:href=\"https:\/\/www.wileyhealthlearning.com\/acs.aspx\">Answer questions and earn CME\/CNE<\/jats:ext-link>\n                  <\/jats:p>\n                  <jats:p>\n                    Extranodal marginal zone lymphoma of the mucosa\u2010associated lymphoid tissue (MALT lymphoma) accounts for 7% to 8% of newly diagnosed lymphomas. Because of its association with infectious causes, such as\n                    <jats:italic>Helicobacter pylori<\/jats:italic>\n                    (HP) or\n                    <jats:italic>Chlamydophila psittaci<\/jats:italic>\n                    (CP), and autoimmune diseases, it has become the paradigm of an antigen\u2010driven malignancy. MALT lymphoma usually displays an indolent course, and watch\u2010and\u2010wait strategies are justified initially in a certain percentage of patients. In patients with gastric MALT lymphoma or ocular adnexal MALT lymphoma, antibiotic therapy against HP or CP, respectively, is the first\u2010line management of choice, resulting in lymphoma response rates from 75% to 80% after HP eradication and from 33% to 65% after antibiotic therapy for CP. In patients who have localized disease that is refractory to antibiotics, radiation is widely applied in various centers with excellent local control, whereas systemic therapies are increasingly being applied, at least in Europe, because of the potentially systemic nature of the disease. Therefore, the objective of this review is to briefly summarize the clinicopathologic characteristics of this distinct type of lymphoma along with current data on management strategies.\n                    <jats:bold>CA Cancer J Clin 2016;66:152\u2013171. \u00a9 2015 American Cancer Society.<\/jats:bold>\n                  <\/jats:p>","DOI":"10.3322\/caac.21330","type":"journal-article","created":{"date-parts":[[2015,11,24]],"date-time":"2015-11-24T09:44:54Z","timestamp":1448358294000},"page":"152-171","source":"Crossref","is-referenced-by-count":195,"title":["Clinicopathologic characteristics and treatment of marginal zone lymphoma of mucosa\u2010associated lymphoid tissue (MALT lymphoma)"],"prefix":"10.3322","volume":"66","author":[{"given":"Markus","family":"Raderer","sequence":"first","affiliation":[{"name":"Programme Director for Extranodal Lymphomas, Department of Internal Medicine I, Division of Oncology Medical University Vienna Vienna Austria"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Barbara","family":"Kiesewetter","sequence":"additional","affiliation":[{"name":"Resident-in-Training, Department of Internal Medicine I, Division of Oncology Medical University Vienna Vienna Austria"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andr\u00e9s J. M.","family":"Ferreri","sequence":"additional","affiliation":[{"name":"Director, Unit of Lymphoid Malignancies, Division of Onco\u2010Hematological Medicine, Department of Onco\u2010Hematology, National Institute for Research and Treatment San Raffaele Scientific Institute Milano Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2015,11,24]]},"reference":[{"key":"e_1_2_9_2_1","first-page":"58","volume-title":"WHO Classification of Tumours of the Haematopoietic and Lymphoid Tissues","author":"Jaffe ES","year":"2008"},{"key":"e_1_2_9_3_1","doi-asserted-by":"publisher","DOI":"10.1002\/1097-0142(19831015)52:8<1410::AID-CNCR2820520813>3.0.CO;2-3"},{"key":"e_1_2_9_4_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2958.1998.00770.x"},{"key":"e_1_2_9_5_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V84.5.1361.1361"},{"key":"e_1_2_9_6_1","first-page":"214","volume-title":"WHO Classification of Tumours of the Haematopoietic and Lymphoid Tissues","author":"Isaacson PG","year":"2008"},{"key":"e_1_2_9_7_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00277-014-2298-3"},{"key":"e_1_2_9_8_1","first-page":"969","article-title":"Retrospective comparison of the effectiveness of various treatment modalities of extragastric MALT lymphoma: a single\u2010center analysis","volume":"94","author":"Wohrer S","year":"2015","journal-title":"Ann Hematol."},{"key":"e_1_2_9_9_1","doi-asserted-by":"publisher","DOI":"10.1023\/A:1008396618983"},{"key":"e_1_2_9_10_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2006.06.0723"},{"key":"e_1_2_9_11_1","doi-asserted-by":"publisher","DOI":"10.3324\/haematol.11835"},{"key":"e_1_2_9_12_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0167-5699(99)01468-1"},{"key":"e_1_2_9_13_1","doi-asserted-by":"publisher","DOI":"10.1002\/hed.21533"},{"key":"e_1_2_9_14_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0104004"},{"key":"e_1_2_9_15_1","doi-asserted-by":"publisher","DOI":"10.3324\/haematol.2011.057422"},{"key":"e_1_2_9_16_1","first-page":"1361","article-title":"Expression of lymphocyte homing receptors and vascular addressins in low\u2010grade gastric B\u2010cell lymphomas of mucosa\u2010associated lymphoid tissue","volume":"151","author":"Dogan A","year":"1997","journal-title":"Am J Pathol."},{"key":"e_1_2_9_17_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V88.12.4445.bloodjournal88124445"},{"key":"e_1_2_9_18_1","doi-asserted-by":"publisher","DOI":"10.1016\/0092-8674(93)90305-A"},{"key":"e_1_2_9_19_1","doi-asserted-by":"publisher","DOI":"10.1038\/modpathol.2012.134"},{"key":"e_1_2_9_20_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2007-10-119974"},{"key":"e_1_2_9_21_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.leu.2404782"},{"key":"e_1_2_9_22_1","doi-asserted-by":"publisher","DOI":"10.1093\/annonc\/mdn049"},{"key":"e_1_2_9_23_1","doi-asserted-by":"publisher","DOI":"10.1093\/jncimonographs\/lgu011"},{"key":"e_1_2_9_24_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199405053301803"},{"key":"e_1_2_9_25_1","doi-asserted-by":"publisher","DOI":"10.1016\/0140-6736(91)92035-Z"},{"key":"e_1_2_9_26_1","first-page":"1271","article-title":"B\u2010cell monoclonality precedes the development of gastric MALT lymphoma in Helicobacter pylori\u2010associated chronic gastritis","volume":"152","author":"Nakamura S","year":"1998","journal-title":"Am J Pathol."},{"key":"e_1_2_9_27_1","doi-asserted-by":"publisher","DOI":"10.1016\/0140-6736(93)91408-E"},{"key":"e_1_2_9_28_1","doi-asserted-by":"publisher","DOI":"10.1007\/PL00008209"},{"key":"e_1_2_9_29_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1462-5822.2006.00843.x"},{"key":"e_1_2_9_30_1","doi-asserted-by":"publisher","DOI":"10.1097\/PAS.0000000000000437"},{"key":"e_1_2_9_31_1","doi-asserted-by":"publisher","DOI":"10.1111\/hel.12033"},{"key":"e_1_2_9_32_1","doi-asserted-by":"publisher","DOI":"10.1097\/MCG.0b013e318286ff72"},{"key":"e_1_2_9_33_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0016-5085(00)70167-3"},{"key":"e_1_2_9_34_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.dld.2012.03.020"},{"key":"e_1_2_9_35_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2005.02.9025"},{"key":"e_1_2_9_36_1","doi-asserted-by":"publisher","DOI":"10.1007\/s11864-015-0344-6"},{"key":"e_1_2_9_37_1","doi-asserted-by":"publisher","DOI":"10.1111\/bjh.12703"},{"key":"e_1_2_9_38_1","doi-asserted-by":"publisher","DOI":"10.1309\/AJCPXMDRT1SY6KIV"},{"key":"e_1_2_9_39_1","doi-asserted-by":"publisher","DOI":"10.1038\/bjc.2012.2"},{"key":"e_1_2_9_40_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2009-07-234021"},{"key":"e_1_2_9_41_1","doi-asserted-by":"publisher","DOI":"10.1038\/nrclinonc.2009.147"},{"key":"e_1_2_9_42_1","doi-asserted-by":"publisher","DOI":"10.1002\/ijc.23596"},{"key":"e_1_2_9_43_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2013-02-486522"},{"key":"e_1_2_9_44_1","doi-asserted-by":"publisher","DOI":"10.1097\/CAD.0b013e32830b58c4"},{"key":"e_1_2_9_45_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2005-06-2332"},{"key":"e_1_2_9_46_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2141.2008.07112.x"},{"key":"e_1_2_9_47_1","doi-asserted-by":"publisher","DOI":"10.1097\/01.pas.0000249445.28713.88"},{"key":"e_1_2_9_48_1","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.22843"},{"key":"e_1_2_9_49_1","doi-asserted-by":"publisher","DOI":"10.1136\/gut.2010.224949"},{"key":"e_1_2_9_50_1","first-page":"7","article-title":"The bcl\u20102 gene in primary B cell lymphoma of mucosa\u2010associated lymphoid tissue (MALT)","volume":"135","author":"Pan L","year":"1989","journal-title":"Am J Pathol."},{"key":"e_1_2_9_51_1","doi-asserted-by":"publisher","DOI":"10.3324\/haematol.11927"},{"key":"e_1_2_9_52_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V85.8.2000.bloodjournal8582000"},{"key":"e_1_2_9_53_1","doi-asserted-by":"publisher","DOI":"10.1038\/modpathol.2008.155"},{"key":"e_1_2_9_54_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V87.1.299.299"},{"key":"e_1_2_9_55_1","doi-asserted-by":"publisher","DOI":"10.1093\/ajcp\/94.5.655"},{"key":"e_1_2_9_56_1","first-page":"643","article-title":"Replication error phenotype and p53 gene mutation in lymphomas of mucosa\u2010associated lymphoid tissue","volume":"148","author":"Peng H","year":"1996","journal-title":"Am J Pathol."},{"key":"e_1_2_9_57_1","doi-asserted-by":"publisher","DOI":"10.1023\/A:1008202303666"},{"key":"e_1_2_9_58_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2002-11-3502"},{"key":"e_1_2_9_59_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V98.4.1182"},{"key":"e_1_2_9_60_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(00)03571-6"},{"key":"e_1_2_9_61_1","doi-asserted-by":"publisher","DOI":"10.1002\/path.1715"},{"key":"e_1_2_9_62_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.leu.2403501"},{"key":"e_1_2_9_63_1","doi-asserted-by":"publisher","DOI":"10.1002\/1098-2264(2000)9999:9999<::AID-GCC1048>3.0.CO;2-B"},{"key":"e_1_2_9_64_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-9440(10)64630-5"},{"key":"e_1_2_9_65_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2002-10-3236"},{"key":"e_1_2_9_66_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.leu.2403185"},{"key":"e_1_2_9_67_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.leu.2403644"},{"key":"e_1_2_9_68_1","doi-asserted-by":"publisher","DOI":"10.1038\/nri1488"},{"key":"e_1_2_9_69_1","doi-asserted-by":"publisher","DOI":"10.3324\/haematol.2011.040402"},{"key":"e_1_2_9_70_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V83.10.2829.2829"},{"key":"e_1_2_9_71_1","doi-asserted-by":"publisher","DOI":"10.1093\/oxfordjournals.annonc.a059184"},{"key":"e_1_2_9_72_1","doi-asserted-by":"publisher","DOI":"10.3109\/10428199709050889"},{"key":"e_1_2_9_73_1","doi-asserted-by":"publisher","DOI":"10.1378\/chest.103.1.201"},{"key":"e_1_2_9_74_1","doi-asserted-by":"publisher","DOI":"10.1093\/annonc\/mdm513"},{"key":"e_1_2_9_75_1","doi-asserted-by":"publisher","DOI":"10.1097\/00006982-200501000-00018"},{"key":"e_1_2_9_76_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2002-04-1279"},{"key":"e_1_2_9_77_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1572-0241.2003.07426.x"},{"key":"e_1_2_9_78_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.0953-0673.1996.00289.x"},{"key":"e_1_2_9_79_1","doi-asserted-by":"publisher","DOI":"10.1136\/gut.46.5.608"},{"key":"e_1_2_9_80_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1572-0241.2003.t01-1-07264.x"},{"key":"e_1_2_9_81_1","doi-asserted-by":"publisher","DOI":"10.1093\/annonc\/mdt343"},{"key":"e_1_2_9_82_1","doi-asserted-by":"publisher","DOI":"10.1093\/annonc\/mdl295"},{"key":"e_1_2_9_83_1","doi-asserted-by":"publisher","DOI":"10.1183\/09031936.00039309"},{"key":"e_1_2_9_84_1","doi-asserted-by":"publisher","DOI":"10.1093\/oxfordjournals.annonc.a058869"},{"key":"e_1_2_9_85_1","doi-asserted-by":"publisher","DOI":"10.1136\/gut.52.6.912"},{"key":"e_1_2_9_86_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ophtha.2003.09.049"},{"key":"e_1_2_9_87_1","doi-asserted-by":"publisher","DOI":"10.1097\/00001622-199509000-00005"},{"key":"e_1_2_9_88_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.1997.15.4.1624"},{"key":"e_1_2_9_89_1","doi-asserted-by":"publisher","DOI":"10.1097\/00000478-199608000-00010"},{"key":"e_1_2_9_90_1","doi-asserted-by":"publisher","DOI":"10.1016\/0016-5085(92)91723-H"},{"key":"e_1_2_9_91_1","doi-asserted-by":"publisher","DOI":"10.1053\/gast.1997.v112.pm9178679"},{"key":"e_1_2_9_92_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0344-0338(11)80904-0"},{"key":"e_1_2_9_93_1","doi-asserted-by":"publisher","DOI":"10.1093\/oxfordjournals.annonc.a058388"},{"key":"e_1_2_9_94_1","doi-asserted-by":"publisher","DOI":"10.1136\/gut.2006.096420"},{"key":"e_1_2_9_95_1","unstructured":"National Comprehensive Cancer Network (NCCN).NCCN Clinical Practice Guidelines in Oncology.nccn.org\/professionals\/physician_gls\/pdf\/nhl.pdf. Accessed November 3 2014."},{"key":"e_1_2_9_96_1","doi-asserted-by":"publisher","DOI":"10.1093\/annonc\/mdj025"},{"key":"e_1_2_9_97_1","first-page":"3633","article-title":"Does MALT lymphoma of the lung require immediate treatment? An analysis of 11 untreated cases with long\u2010term follow\u2010up","volume":"27","author":"Troch M","year":"2007","journal-title":"Anticancer Res."},{"key":"e_1_2_9_98_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.radonc.2005.11.005"},{"key":"e_1_2_9_99_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2003.06.085"},{"key":"e_1_2_9_100_1","doi-asserted-by":"publisher","DOI":"10.1136\/gut.2006.101634"},{"key":"e_1_2_9_101_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.cgh.2009.07.017"},{"key":"e_1_2_9_102_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2141.2008.07486.x"},{"key":"e_1_2_9_103_1","doi-asserted-by":"publisher","DOI":"10.1111\/bjh.12078"},{"key":"e_1_2_9_104_1","doi-asserted-by":"publisher","DOI":"10.1136\/gut.2005.083022"},{"key":"e_1_2_9_105_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2005.07.083"},{"key":"e_1_2_9_106_1","doi-asserted-by":"publisher","DOI":"10.1093\/jnci\/djj373"},{"key":"e_1_2_9_107_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2011.41.4466"},{"key":"e_1_2_9_108_1","doi-asserted-by":"publisher","DOI":"10.1093\/annonc\/mdm561"},{"key":"e_1_2_9_109_1","doi-asserted-by":"publisher","DOI":"10.1093\/jnci\/djm118"},{"key":"e_1_2_9_110_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00277-014-2240-8"},{"key":"e_1_2_9_111_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1349-7006.2010.01502.x"},{"key":"e_1_2_9_112_1","doi-asserted-by":"publisher","DOI":"10.1111\/1523-1747.ep12285646"},{"key":"e_1_2_9_113_1","doi-asserted-by":"publisher","DOI":"10.1007\/s001050050005"},{"key":"e_1_2_9_114_1","doi-asserted-by":"publisher","DOI":"10.1093\/annonc\/mdu166"},{"key":"e_1_2_9_115_1","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2003.09.025"},{"key":"e_1_2_9_116_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2893.2011.01515.x"},{"key":"e_1_2_9_117_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.1995.13.10.2524"},{"key":"e_1_2_9_118_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2011.40.6272"},{"issue":"1","key":"e_1_2_9_119_1","first-page":"97","article-title":"Chlorambucil plus rituximab produces better event\u2010free survival in comparison with chlorambucil or rituximab alone in extranodal marginal zone B\u2010cell lymphoma (MALT lymphoma): final results of the IELSG\u201019 study [abstract]","volume":"31","author":"Zucca E","year":"2013","journal-title":"Hematol Oncol."},{"key":"e_1_2_9_120_1","doi-asserted-by":"publisher","DOI":"10.3109\/10428194.2012.729832"},{"key":"e_1_2_9_121_1","doi-asserted-by":"publisher","DOI":"10.1016\/S2352-3026(14)00021-0"},{"key":"e_1_2_9_122_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00277-013-1865-3"},{"key":"e_1_2_9_123_1","doi-asserted-by":"publisher","DOI":"10.1159\/000098555"},{"key":"e_1_2_9_124_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2002.05.117"},{"key":"e_1_2_9_125_1","doi-asserted-by":"publisher","DOI":"10.3324\/haematol.2012.072587"},{"key":"e_1_2_9_126_1","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.20237"},{"key":"e_1_2_9_127_1","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.24605"},{"key":"e_1_2_9_128_1","doi-asserted-by":"publisher","DOI":"10.1634\/theoncologist.2015-0109"},{"key":"e_1_2_9_129_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(12)61763-2"},{"key":"e_1_2_9_130_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2005.08.100"},{"key":"e_1_2_9_131_1","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-04-2282"},{"key":"e_1_2_9_132_1","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1182\/blood.V95.3.802.003k19_802_806","article-title":"Mucosa\u2010associated lymphoid tissue is a disseminated disease in one third of 158 patients analyzed","volume":"95","author":"Thieblemont C","year":"2000","journal-title":"Blood."},{"key":"e_1_2_9_133_1","doi-asserted-by":"publisher","DOI":"10.1136\/gutjnl-2012-302254"},{"key":"e_1_2_9_134_1","doi-asserted-by":"publisher","DOI":"10.1038\/ajg.2009.314"},{"key":"e_1_2_9_135_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2002-11-3496"},{"key":"e_1_2_9_136_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2005.08.128"},{"key":"e_1_2_9_137_1","doi-asserted-by":"publisher","DOI":"10.1080\/10428190701457949"},{"key":"e_1_2_9_138_1","doi-asserted-by":"publisher","DOI":"10.1093\/annonc\/mdn636"},{"key":"e_1_2_9_139_1","doi-asserted-by":"publisher","DOI":"10.1093\/annonc\/mds644"},{"key":"e_1_2_9_140_1","doi-asserted-by":"publisher","DOI":"10.3324\/haematol.2008.001537"},{"key":"e_1_2_9_141_1","doi-asserted-by":"publisher","DOI":"10.1093\/annonc\/mdq416"},{"key":"e_1_2_9_142_1","doi-asserted-by":"publisher","DOI":"10.1093\/annonc\/mdp349"},{"key":"e_1_2_9_143_1","doi-asserted-by":"publisher","DOI":"10.3324\/haematol.2012.065995"},{"key":"e_1_2_9_144_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2141.2010.08179.x"},{"key":"e_1_2_9_145_1","doi-asserted-by":"publisher","DOI":"10.1093\/annonc\/mdv214"},{"key":"e_1_2_9_146_1","unstructured":"RadererM KiesewetterB WillenbacherW et al.Rituximab + lenalidomide in MALT lymphoma: final results. Presented at: 2015 13th International Conference on Malignant Lymphoma; June 17\u201320 2015; Lugano Switzerland."},{"key":"e_1_2_9_147_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1314583"},{"key":"e_1_2_9_148_1","doi-asserted-by":"publisher","DOI":"10.1097\/MEG.0b013e32834d85e6"}],"container-title":["CA: A Cancer Journal for Clinicians"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.3322%2Fcaac.21330","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/acsjournals.onlinelibrary.wiley.com\/doi\/pdf\/10.3322\/caac.21330","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,5]],"date-time":"2025-11-05T16:50:37Z","timestamp":1762361437000},"score":1,"resource":{"primary":{"URL":"https:\/\/acsjournals.onlinelibrary.wiley.com\/doi\/10.3322\/caac.21330"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,11,24]]},"references-count":147,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2016,3]]}},"alternative-id":["10.3322\/caac.21330"],"URL":"https:\/\/doi.org\/10.3322\/caac.21330","archive":["Portico"],"relation":{},"ISSN":["0007-9235","1542-4863"],"issn-type":[{"value":"0007-9235","type":"print"},{"value":"1542-4863","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,11,24]]}}}